0001800934-21-000001.txt : 20210408 0001800934-21-000001.hdr.sgml : 20210408 20210407190208 ACCESSION NUMBER: 0001800934-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210408 DATE AS OF CHANGE: 20210407 EFFECTIVENESS DATE: 20210408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Revel Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001800934 IRS NUMBER: 842338101 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-395021 FILM NUMBER: 21813424 BUSINESS ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 217-766-4292 MAIL ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 D 1 primary_doc.xml X0708 D LIVE 0001800934 Revel Pharmaceuticals Inc. 953 INDIANA STREET SAN FRANCISCO CA CALIFORNIA 94107 217-766-4292 DELAWARE None None Corporation true 2019 Aaron Cravens 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Jennifer Cochran 953 Indiana St San Francisco CA CALIFORNIA 94107 Director Biotechnology No Revenues 06b false 2021-03-24 false true true false 100000 1600000 800000 800000 false 2 0 0 168000 Amount represents yearly compensation false Revel Pharmaceuticals Inc. Aaron Cravens Aaron Cravens CEO 2021-04-07